International Comparative Legal Guide - Drug & Medical Device Litigation

Welcome to the inaugural edition of International Comparative Legal Guide - Drug & Medical Device Litigation, intended to provide global insight into litigation considerations critical to the life science industry and practitioners around the world, including from a regulatory and commercial perspective.

---

Welcome to the inaugural edition of International Comparative Legal Guide - Drug & Medical Device Litigation. Sidley Austin LLP is honoured to be the Contributing Editor of ICLG's first treatise intended to provide global insight into litigation considerations critical to the life science industry and practitioners around the world, including from a regulatory and commercial perspective.
In our ever-interlocking global economy, it is an imperative to understand the cutting-edge issues and legal regimes which cut across markets and legal systems. The development of life-saving medications and devices at one end of the world may carry litigation risk across the globe to manufacturers, sellers, distributors, healthcare providers and patients in other parts of the world. This Guide provides valuable information which all entities and individuals in the supply chain need to consider, the potential ramifications at many different levels and ways to mitigate those litigation risks, where applicable.
As the times we live in illustrate, we may be physically remote but we are all connected in so many different ways via various media. Indeed, even the COVID-19 crisis itself implicates some of the very issues discussed in these pages. Drawing on the extensive, diverse experience and knowledge of the authors worldwide, cutting across a panoply of practice areas, we explore how medications and devices are approved for marketing, regulatory processes, clinical trials, data privacy, compassionate use programmes, product recalls and litigation (and other dispute resolution proceedings), including whether there are any jurisdictional inhibitions to subjecting an entity to lawsuits in another country. We thank all of our fellow contributors for sharing their insights with us.
We hope you find this Guide to be helpful and practical as you navigate the legal challenges in the life sciences industry.